Press Releases May 18, 2026 04:05 PM

Latham Group, Inc. to Participate at Conferences in May and June 2026

Latham Group Announces Participation in Major Investor Conferences in May and June 2026

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
SWIM

Latham Group, Inc., a leading designer, manufacturer, and marketer of residential in-ground swimming pools in North America, Australia, and New Zealand, announced that its management team will attend and present at several prominent investor conferences in May and June 2026, including the Craig-Hallum Institutional Investor Conference, Baird Global Consumer, Technology & Services Conference, and William Blair 46th Annual Growth Stock Conference.

Latham Group, Inc. to Participate at Conferences in May and June 2026
SWIM
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Latham Group to present and hold investor meetings at three major investor conferences in the U.S. during May and June 2026.
  • Company emphasizes its leadership position in the residential in-ground swimming pool market across North America, Australia, and New Zealand with a large operational platform.
  • Investor engagement events include presentations and a fireside chat with senior management, indicating active communication with investors and analysts.

LATHAM, N.Y., May 18, 2026 (GLOBE NEWSWIRE) -- Latham Group, Inc. (NASDAQ:SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced that management will attend the following investor conferences:

  • On May 28, 2026, Oliver Gloe, Chief Financial Officer, and Joshua Rickaby, Fiberglass Sales – Sand States, will host investor meetings at the Craig-Hallum Institutional Investor Conference. This event will take place at the Renaissance Minneapolis Hotel in Minneapolis, MN.
  • On June 2, 2026, Oliver Gloe, Chief Financial Officer, and Chris Daley, Vice President – Finance, will host a fireside chat at 9:05am ET at the Baird Global Consumer, Technology & Services Conference. This event will take place at the InterContinental New York Barclay in New York, NY. Latham’s management team will also host investor meetings throughout the day.
  • On June 4, 2026, Oliver Gloe, Chief Financial Officer, and Joshua Rickaby, Fiberglass Sales – Sand States, will host a presentation at 10:00am CT at the William Blair 46th Annual Growth Stock Conference. This event will take place at the Loews Chicago Hotel in Chicago, IL. Latham’s management team will also host investor meetings throughout the day.

About Latham Group, Inc.
Latham Group, Inc., headquartered in Latham, NY, is the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand. Latham has a coast-to-coast operations platform consisting of approximately 1,900 employees across around 35 locations.

Contact:
Lynn Morgen
Casey Kotary
ADVISIRY Partners
lathamir@advisiry.com
212-750-5800


Risks

  • The press release does not disclose any new financial results or guidance, so there is limited immediate information for investors to react to, possibly resulting in neutral stock impact.
  • Market demand for residential swimming pools is sensitive to economic cycles and weather conditions, which remain underlying risks to the company’s performance.
  • Uncertainties inherent to the competitive consumer discretionary sector and potential impacts from economic or trade developments could affect future business outcomes.

More from Press Releases

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026